Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment

Article indépendant

MOHAMED, Mostafa R. | KYI, Kaitlin | MOHILE, Supriya G. | XU, Huiwen | CULAKOVA, Eva | LOH, Kah Poh | FLANNERY, Marie | OBRECHT, Spencer | RAMSDALE, Erika | PATIL, Amita | DUNNE, Richard F. | DIGIOVANNI, Grace | HEZEL, Aram | BURNETTE, Brian | DESAI, Nisarg | GIGUERE, Jeffrey | MAGNUSON, Allison

Introduction: Treatment toxicities are common in older adults with cancer and consequently, treatment modifications are sometimes considered. We evaluated the prevalence and factors associated with treatment modifications at the first cycle in older patients receiving palliative systemic treatment. Methods: Patients (n = 369) from the GAP 70+ Trial (NCT02054741; PI: Mohile) usual care arm were included. Enrolled patients were aged 70+ with advanced cancer and = 1 Geriatric Assessment (GA) domain impairment. Treatment modification was defined as any change from National Comprehensive Cancer Network guidelines or published clinical trials. Baseline variables included: 1) sociodemographic factors; 2) clinical variables; 3) GA domains; and 4) physician beliefs about life expectancy. Bivariate analyses and multivariable cluster-weighted generalized estimating equation model were conducted to assess the association of baseline variables with cycle 1 treatment modifications. Results: Mean age was 77.2 years (range: 70-94); 62% had lung or gastrointestinal cancers, and 35% had treatment modifications at cycle 1. Increasing age by one year (odds ratio (OR) 1.1, 95% confidence interval [CI] 1.0-1.2), receipt of =second line of chemotherapy (OR 1.8, CI 1.1-3.0), functional impairment (OR 1.6, CI 1.1-2.3) and income =$50,000 (OR 1.7, CI 1.1-2.4) were independently associated with a higher likelihood of cycle 1 treatment modification. Conclusion: Treatment modifications occurred in 35% of older adults with advanced cancer at cycle 1. Increasing age, receipt of =second line of chemotherapy, functional impairment, and lower income were independently associated with treatment modifications. These findings emphasize the need for evidence-based regimens in older adults with cancer and GA impairments.

https://www.sciencedirect.com/science/article/pii/S1879406821001429?via%3Dihub

Voir la revue «Journal of geriatric oncology»

Autres numéros de la revue «Journal of geriatric oncology»

Consulter en ligne

Suggestions

Du même auteur

Prevalence of and factors associated with tre...

Article | MOHAMED, Mostafa R. | Journal of geriatric oncology

Introduction: Treatment toxicities are common in older adults with cancer and consequently, treatment modifications are sometimes considered. We evaluated the prevalence and factors associated with treatment modifications at the f...

Prevalence of and factors associated with tre...

Article indépendant | MOHAMED, Mostafa R. | Journal of geriatric oncology

Introduction: Treatment toxicities are common in older adults with cancer and consequently, treatment modifications are sometimes considered. We evaluated the prevalence and factors associated with treatment modifications at the f...

Advance care planning in older patients with ...

Article indépendant | LOCASTRO, Marissa | Journal of geriatric oncology

INTRODUCTION: Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) have worse survival rates compared to younger patients, and experience more intense inpatient healthcare at the end of life (EOL) c...

De la même série

Effects of comprehensive geriatric assessment...

Article indépendant | GIGER, Ann-Kristine W. | Journal of geriatric oncology | n°1 | vol.15

INTRODUCTION: Older patients with frailty starting oncological treatment are at higher risk of experiencing declining physical performance, loss of independence, and quality of life (QoL). This study examines whether comprehensive...

Comparing the use of aggressive end-of life c...

Article indépendant | SACHDEV, Rishi | Journal of geriatric oncology | n°2 | vol.15

INTRODUCTION: Despite mounting consensus that end-of-life (EOL) care for patients with cancer should focus on improving quality of life, many patients continue to receive aggressive, disease-oriented treatment until death. Within ...

Predictors of high-intensity care at the end ...

Article indépendant | BAIRD, Courtney E. | Journal of geriatric oncology | n°5 | vol.15

INTRODUCTION: High-intensity end-of-life (EoL) care can be burdensome for patients, caregivers, and health systems and does not confer any meaningful clinical benefit. Yet, there are significant knowledge gaps regarding the predic...

Shared decision-making support program for ol...

Article indépendant | OBAMA, Kyoko | Journal of geriatric oncology | n°5 | vol.15

INTRODUCTION: Older patients with cancer are less likely to express their treatment preferences than younger patients. Question prompt lists (QPLs) facilitate communication between patients and physicians. Geriatric assessment (GA...

Potentially inappropriate medication use base...

Article indépendant | KIM, Sunghwan | Journal of geriatric oncology | n°3 | vol.14

INTRODUCTION: We aimed to estimate the nationwide prevalence of potentially inappropriate medication (PIM) use in patients with terminal cancer according to two deprescribing criteria for patients with a limited lifespan. MATERIAL...

Chargement des enrichissements...